South Africa's Tutu discharged from hospital after surgery
- Record-setting rally pushes on as S&P ends week up 3 percent
- Trump's Cohn Pick Most Bullish Sign Yet for Banks - Cowen
- Unusual 11 Mid-Day Movers: (IDXG) (INVN) (EBS) Higher; (SCON) (DTEA) (DLTH) Lower (more...)
- 21st Century Fox (FOXA) offers to acquire Sky for GBP10.75/share
- Coca Cola (KO) Announces James Quincey to Succeed Muhtar Kent as CEO; Kent to Continue as Chairman
The former Anglican archbishop of Cape Town Desmond Tutu waits to receive the 2013 Templeton Prize at the Guildhall in central London in this file photo dated May 21, 2013. REUTERS/Paul Hackett/File Photo
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
CAPE TOWN (Reuters) - South African cleric and anti-apartheid icon Desmond Tutu was discharged from hospital on Wednesday after a successful surgery to treat recurring infections that have afflicted him for more than a year, his family said on Wednesday.
The 84-year-old Nobel Peace Prize winner has struggled with ill health in recent years, but his family has not said whether his current ailment is related to the prostate cancer Tutu has battled with for nearly two decades.
"Archbishop Emeritus Desmond Tutu was this morning discharged from the Cape Town hospital where he has spent the past three weeks," the brief family statement said.
Tutu, the former Anglican archbishop of Cape Town, spoke against white-minority rule from his pulpit, earning him global acclaim.
(Writing by Nqobile Dludla; Editibg by by Tiisetso Motsoeneng)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- At least 10 killed by collapse of church in southern Nigeria: resident
- Suicide bomber kills at least 50 Yemeni troops in Aden
- Car bomb explodes outside Somalia capital Mogadishu's port, three killed: police
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!